Financhill
Buy
54

WKSP Quote, Financials, Valuation and Earnings

Last price:
$0.83
Seasonality move :
10.35%
Day range:
$0.79 - $0.86
52-week range:
$0.36 - $1.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.12x
P/B ratio:
1.68x
Volume:
1.3M
Avg. volume:
2.6M
1-year change:
-38.51%
Market cap:
$27.5M
Revenue:
$1.5M
EPS (TTM):
-$0.66
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $1.9M $346.1K $303.8K $116.5K $1.5M
Revenue Growth (YoY) 300.07% -82.03% -12.25% -61.65% 1212.97%
 
Cost of Revenues $1.7M $299K $350.7K $57K $1.3M
Gross Profit $238.6K $47.2K -$47K $59.5K $240.5K
Gross Profit Margin 12.38% 13.62% -15.46% 51.1% 15.72%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $804.3K $1M $7.5M $12.8M $15M
Other Inc / (Exp) $278.7K $181.1K -$48.3K $526.2K $187.3K
Operating Expenses $804.3K $1M $7.5M $12.8M $15M
Operating Income -$565.7K -$982.4K -$7.6M -$12.8M -$14.7M
 
Net Interest Expenses $72K $386.2K $291.2K $276.4K $376.9K
EBT. Incl. Unusual Items -$359K -$1.2M -$7.9M -$12.5M -$14.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$359K -$1.2M -$7.9M -$12.5M -$14.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$359K -$1.2M -$7.9M -$12.5M -$14.9M
 
Basic EPS (Cont. Ops) -$0.20 -$0.43 -$0.69 -$0.73 -$0.84
Diluted EPS (Cont. Ops) -$0.20 -$0.43 -$0.69 -$0.73 -$0.84
Weighted Average Basic Share $1.8M $2.7M $11.5M $17.1M $17.7M
Weighted Average Diluted Share $1.8M $2.7M $11.5M $17.1M $17.7M
 
EBITDA -$275.6K -$774.4K -$7.5M -$11.6M -$13.2M
EBIT -$287.1K -$801.4K -$7.6M -$12M -$14.3M
 
Revenue (Reported) $1.9M $346.1K $303.8K $116.5K $1.5M
Operating Income (Reported) -$565.7K -$982.4K -$7.6M -$12.8M -$14.7M
Operating Income (Adjusted) -$287.1K -$801.4K -$7.6M -$12M -$14.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $116.5K $93.4K $18.4K $458.5K $3.1M
Revenue Growth (YoY) -86.61% -19.82% -80.36% 2398.55% 581.02%
 
Cost of Revenues $94.1K $81.8K $12.6K $368.8K $2.9M
Gross Profit $22.4K $11.6K $5.8K $89.7K $247.2K
Gross Profit Margin 19.19% 12.42% 31.32% 19.56% 7.92%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $390.4K $2.1M $3M $4M $4.2M
Other Inc / (Exp) -$46.9K $11.2K $125.4K $47.3K $5.8K
Operating Expenses $390.4K $2.1M $3M $4M $4.2M
Operating Income -$368K -$2.1M -$3M -$3.9M -$3.9M
 
Net Interest Expenses $190.1K $24.3K $43.4K $74.8K $229.7K
EBT. Incl. Unusual Items -$605K -$2.1M -$2.9M -$3.9M -$4.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$605K -$2.1M -$2.9M -$3.9M -$4.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$605K -$2.1M -$2.9M -$3.9M -$4.1M
 
Basic EPS (Cont. Ops) -$0.21 -$0.15 -$0.17 -$0.23 -$0.14
Diluted EPS (Cont. Ops) -$0.21 -$0.15 -$0.17 -$0.23 -$0.14
Weighted Average Basic Share $2.9M $14M $17.2M $17.4M $29.4M
Weighted Average Diluted Share $2.9M $14M $17.2M $17.4M $29.4M
 
EBITDA -$408.1K -$2M -$2.4M -$3.3M -$3.5M
EBIT -$414.9K -$2M -$2.8M -$3.8M -$3.9M
 
Revenue (Reported) $116.5K $93.4K $18.4K $458.5K $3.1M
Operating Income (Reported) -$368K -$2.1M -$3M -$3.9M -$3.9M
Operating Income (Adjusted) -$414.9K -$2M -$2.8M -$3.8M -$3.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $191K $409.8K $93.9K $729.3K $6.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $394.7K $398.3K $129.9K $540.2K $5.7M
Gross Profit -$203.7K $11.5K -$36K $189.1K $673.4K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $903K $4.2M $12.7M $15.1M $15.7M
Other Inc / (Exp) -$55K $240.9K $153.9K $453.4K $112.5K
Operating Expenses $903K $4.2M $12.7M $15.1M $15.7M
Operating Income -$1.1M -$4.2M -$12.8M -$14.9M -$15M
 
Net Interest Expenses $288.9K $382.7K $241.5K $282.1K $632K
EBT. Incl. Unusual Items -$1.5M -$4.3M -$12.9M -$14.7M -$15.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$1.5M -$4.3M -$12.9M -$14.7M -$15.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.5M -$4.3M -$12.9M -$14.7M -$15.5M
 
Basic EPS (Cont. Ops) -$0.64 -$0.52 -$0.81 -$0.86 -$0.66
Diluted EPS (Cont. Ops) -$0.64 -$0.52 -$0.81 -$0.86 -$0.66
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$1.1M -$3.8M -$12M -$13.1M -$13.8M
EBIT -$1.2M -$4M -$12.5M -$14.1M -$14.9M
 
Revenue (Reported) $191K $409.8K $93.9K $729.3K $6.4M
Operating Income (Reported) -$1.1M -$4.2M -$12.8M -$14.9M -$15M
Operating Income (Adjusted) -$1.2M -$4M -$12.5M -$14.1M -$14.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $223.6K $287.3K $77.4K $690.3K $5.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $180K $279.4K $58.6K $541.9K $5M
Gross Profit $43.6K $7.9K $18.9K $148.4K $581.3K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $676.8K $3.9M $9.1M $11.3M $12M
Other Inc / (Exp) -$39.4K $20.4K $222.6K $149.8K $75K
Operating Expenses $676.8K $3.9M $9.1M $11.3M $12M
Operating Income -$633.2K -$3.8M -$9.1M -$11.2M -$11.5M
 
Net Interest Expenses $276.8K $273.3K $223.5K $229.2K $484.4K
EBT. Incl. Unusual Items -$949.5K -$4.1M -$9.1M -$11.3M -$11.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$949.5K -$4.1M -$9.1M -$11.3M -$11.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$949.5K -$4.1M -$9.1M -$11.3M -$11.9M
 
Basic EPS (Cont. Ops) -$0.36 -$0.47 -$0.54 -$0.66 -$0.47
Diluted EPS (Cont. Ops) -$0.36 -$0.47 -$0.54 -$0.66 -$0.47
Weighted Average Basic Share $7.5M $29M $51.2M $51.8M $76.6M
Weighted Average Diluted Share $7.5M $29M $51.2M $51.8M $76.6M
 
EBITDA -$652.6K -$3.7M -$8.2M -$9.8M -$10.4M
EBIT -$672.6K -$3.8M -$8.8M -$10.8M -$11.4M
 
Revenue (Reported) $223.6K $287.3K $77.4K $690.3K $5.6M
Operating Income (Reported) -$633.2K -$3.8M -$9.1M -$11.2M -$11.5M
Operating Income (Adjusted) -$672.6K -$3.8M -$8.8M -$10.8M -$11.4M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $12K $1.1M $28.6M $14.2M $2.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3K $122.8K $62.7K $62.6K $463.1K
Inventory $113.2K $40.8K $501.8K $1.3M $3.6M
Prepaid Expenses $60.7K $245.5K $4.7M $2M $1.5M
Other Current Assets -- -- -- -- --
Total Current Assets $253.7K $1.7M $34M $18.3M $9.1M
 
Property Plant And Equipment $154.8K $130K $1.6M $13.1M $15.4M
Long-Term Investments $15.7K $24.4K $24.4K $24.4K $90.7K
Goodwill -- -- -- -- --
Other Intangibles $57.2K $63K $593.1K $1.3M $1.3M
Other Long-Term Assets -- -- -- -- --
Total Assets $481.3K $1.9M $36.3M $32.8M $26M
 
Accounts Payable $969.3K $971.7K $1.1M $2M $1.5M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $28.6K $307.2K $63.9K $46.1K $5.3M
Current Portion Of Capital Lease Obligations $22K $23.9K $212.9K $387.3K $328.2K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.3M $1.7M $1.8M $2.5M $7.2M
 
Long-Term Debt -- -- -- $5.3M --
Capital Leases -- -- -- -- --
Total Liabilities $1.4M $1.7M $2.1M $8.6M $7.8M
 
Common Stock $4.2K $380 $1.7K $1.7K $2K
Other Common Equity Adj -- -- -- -- --
Common Equity -$882.6K $169.5K $34.2M $24.1M $18.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$882.6K $169.5K $34.2M $24.1M $18.2M
 
Total Liabilities and Equity $481.3K $1.9M $36.3M $32.8M $26M
Cash and Short Terms $12K $1.1M $28.6M $14.2M $2.6M
Total Debt $296.5K $674.3K $327.1K $5.3M $5.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $467.1K $29M $16.7M $3M $1.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $125.6K $155.3K $63.1K $518.1K $466.4K
Inventory $68.7K $56.2K $1.3M $3.6M $6.1M
Prepaid Expenses $126.9K $5.5M $3.2M $694.3K $256.6K
Other Current Assets -- -- -- -- --
Total Current Assets $907.6K $36.8M $22.1M $7.9M $8.9M
 
Property Plant And Equipment $136.4K $1.4M $12.6M $15.3M $14.6M
Long-Term Investments $24.4K $24.4K $24.4K $90.7K $90.7K
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $1.1M $38.6M $35.7M $24.6M $24.9M
 
Accounts Payable $916.3K $1.2M $1.8M $1.9M $2.5M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $209.1K $28.4K $49.7K $5.3M $190K
Current Portion Of Capital Lease Obligations $23.3K $214.3K $375.9K $342K $248.5K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.6M $1.7M $2.5M $7.6M $3M
 
Long-Term Debt -- -- $5.3M -- $5.1M
Capital Leases -- -- -- -- --
Total Liabilities $1.6M $2.1M $8.8M $8.2M $8.6M
 
Common Stock $6.1K $1.7K $1.7K $1.7K $3.1K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$444.3K $36.5M $26.9M $16.4M $16.4M
 
Total Liabilities and Equity $1.1M $38.6M $35.7M $24.6M $24.9M
Cash and Short Terms $467.1K $29M $16.7M $3M $1.9M
Total Debt $593.1K $291.6K $5.6M $5.3M $5.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$359K -$1.2M -$7.9M -$12.5M -$14.9M
Depreciation & Amoritzation $11.4K $27K $66.9K $486.6K $1.1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$5.9K -$241.2K -$19.1K -$83.2K -$298.4K
Change in Inventories $122.1K $72.4K -$461K -$844.6K -$2.3M
Cash From Operations -$2.2K -$695.1K -$4.2M -$8M -$11.9M
 
Capital Expenditures $108.4K $8K $1.1M $11.2M $3.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$124.1K -$16.7K -$1.1M -$11.2M -$3.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $88.1K $646.3K -- $5.3M --
Long-Term Debt Repaid -$19.5K -$47.3K -$62.9K -$128.4K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $19.3K $201.1K $12.2K -- --
Cash From Financing $117.8K $1.8M $32.8M $5.2M $4.4M
 
Beginning Cash (CF) $25.3K $12K $1.1M $28.6M $14.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$8.4K $1.1M $27.5M -$13.9M -$11.3M
Ending Cash (CF) $12K $1.1M $28.6M $14.6M $3.4M
 
Levered Free Cash Flow -$110.5K -$703.1K -$5.3M -$19.1M -$15.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$605K -$2.1M -$2.9M -$3.9M -$4.1M
Depreciation & Amoritzation $6.8K $76K $380.9K $558.4K $403.9K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$99.6K -$96.4K -$75.5K -$54.4K $143.8K
Change in Inventories $44.4K $55.5K -$184.1K -$672.2K $248.7K
Cash From Operations -$152.8K -$1.1M -$1.3M -$2.2M -$1.5M
 
Capital Expenditures $8K $477.6K $1.2M $849.4K $165K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$8K -$477.6K -$1.2M -$849.4K -$165K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $403K -- -- -- $8.8M
Long-Term Debt Repaid -$41.5K -- -- -- -$8.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$4.7K -$22.9K -- -$43.9K -$16.5K
Cash From Financing $606.8K $20.2M -- $88.4K $134.5K
 
Beginning Cash (CF) $21.1K $12.3M $19.8M $5.9M $3.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $446K $18.7M -$2.5M -$2.9M -$1.6M
Ending Cash (CF) $467.1K $30.9M $17.3M $3M $1.9M
 
Levered Free Cash Flow -$160.8K -$1.6M -$2.5M -$3M -$1.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.5M -$4.3M -$12.9M -$14.7M -$15.5M
Depreciation & Amoritzation $6.4K $121K $485.9K $973K $1.1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $82.2K -$104.4K -$150.8K -$340.2K $61.7K
Change in Inventories $75.5K -$128.9K -$1.1M -$2.3M -$2.6M
Cash From Operations -$669.6K -$2.4M -$8.5M -$9.8M -$11.7M
 
Capital Expenditures $32.2K $758.6K $10.6M $4.4M $744.7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$41K -$764.1K -$10.6M -$4.5M -$744.7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $734.5K -- -- -- --
Long-Term Debt Repaid -$41.7K -$68.7K -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $18.7K $152.8K $75.1K -$58K $27.4K
Cash From Financing $961.5K $33.6M $5.4M -$51.9K $11.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $250.8K $30.5M -$13.6M -$14.3M -$1.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$701.8K -$3.2M -$19M -$14.2M -$12.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$949.5K -$4.1M -$9.1M -$11.3M -$11.9M
Depreciation & Amoritzation $20K $114K $533.1K $1M $1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$99.6K $37.1K -$94.5K -$351.5K $8.6K
Change in Inventories $44.4K -$156.8K -$785K -$2.2M -$2.5M
Cash From Operations -$382.4K -$2.1M -$6.4M -$8.2M -$8M
 
Capital Expenditures $8K $758.6K $10.2M $3.4M $500.8K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$16.7K -$764.1K -$10.2M -$3.5M -$500.8K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $646.3K -- $5.3M -- $8.8M
Long-Term Debt Repaid -$41.5K -$62.9K -$28.4K -- -$8.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$610 -$48.9K $14.1K -$43.9K -$16.5K
Cash From Financing $854.2K $32.7M $5.3M $51.6K $7M
 
Beginning Cash (CF) $44.1K $22.7M $74.1M $31M $10.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $455.1K $29.8M -$11.3M -$11.7M -$1.5M
Ending Cash (CF) $499.3K $52.5M $62.8M $19.4M $8.8M
 
Levered Free Cash Flow -$390.3K -$2.9M -$16.6M -$11.6M -$8.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock